Human sera were tested for antibodies against the Epstein-Barr virus (EBV) latent infection terminal proteins (TPs). Anti-TP IgG and IgA antibodies were detected by an indirect immunofluorescence assay of insect cells expressing a recombinant TP1. Out of 301 human sera of patients with EBV-related and EBV-unrelated disorders, only sera from patients with nasopharyngeal carcinoma (NPC) (32/83; 38%) showed anti-TP antibodies. Studies on serial sera from German and Hong Kong NPC patients revealed a decline of anti-TP antibodies during tumour therapy, and none of these antibodies were identified in patients with early tumour stages or in remission. Comparative studies of TP1-specific polyclonal rabbit antisera and human TP-positive sera showed clear differences in the TP epitopes recognized by each. Human antisera contained antibodies only to native epitopes in exons 2 to 7 of TP1 whereas rabbit antisera reacted only with epitopes located in the first exon and, additionally, exhibited EBV strain specificities.
ChenJ. Y.,
HwangL. Y.,
BeasleyR. P.,
ChienC. S.,
YangC. S.1985; Antibody response to Epstein-Barr virus-specific DNAse in 15 patients with nasopharyngeal carcinoma in Taiwan: a retrospective study. Journal of Medical Virology 244:245–247
CrawfordD. H.,
EpsteinM. A.,
BornkammG. W.,
AchongB. G.,
FinertyS.,
ThompsonJ.1979; Biological and biochemical observations on isolates of EB virus from the malignant epithelial cells of two nasopharyngeal carcinomas. International Journal of Cancer 24:294–302
De TheG.1982 Epidemiology of Epstein-Barr virus and associated diseases in man. In The Herpesviruses vol. 1 pp. 25–103 Edited by
RoizmanB.
New York: Plenum Press;
FoongY. T.,
ChengH. M.,
SamC. K.,
DillnerJ.,
HindererW.,
PrasadU.1990; Serum and salivary IgA antibodies against a defined epitope of the Epstein-Barr virus nuclear antigen (EBNA) are elevated in nasopharyngeal carcinoma. International Journal of Cancer 45:1061–1064
FrechB.,
Zimber-StroblU.,
SuentzenichK.-O.,
PavlishO.,
LenoirG. M.,
BornkammG. W.,
Mueller-LantzschN.1990; Identification of Epstein-Barr virus terminal protein 1 (TP1) in extracts of four lymphoid cell lines, expression in insect cells and detection of antibodies in human sera. Journal of Virology 64:2759–2767
HadarT.,
RakinaM.,
KalaE.1986; Significance of specific Epstein-Barr virus IgA and elevated IgG antibodies to viral capsid antigens in nasopharyngeal carcinoma patients. Journal of Medical Virology 20:329–339
HenleG.,
HenleW.1976; Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. International Journal of Cancer 17:1–7
HenleW.,
HoJ. H. C.,
HenleG.,
KwanH. C.1973; Antibodies to Epstein-Barr virus related antigens in nasopharyngeal carcinoma. Comparison of active cases and long term survivors. Journal of the National Cancer Institute 51:361–369
HenleW.,
HoJ. H. C.,
HenleG.,
ChouJ. C. W.,
KwanH. C.1977; Nasopharyngeal carcinoma: significance of changes in Epstein-Barr virus related antibody patterns following therapy. International Journal of Cancer 20:663–672
HerbstH.,
DallenbachF.,
HummelM.,
NiedobitekG.,
PileriS.,
Mueller-LantzschN.,
SteinH.1991; Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proceedings of the National Academy of Sciences, U.S.A. 88:4766–4770
HinumaY.,
KannM.,
YamaguchiI.,
WudarskiJ.,
BlakesteeJ. R.,
GraceJ. T.1967; Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line. Journal of Virology 1:1045–1051
KieffE.,
LiebowitzD.1990 Epstein-Barr virus and its replication. In Virology, 2nd edn. pp. 1889–1920 Edited by
FieldsB. N.,
KnipeD. M.
New York: Raven Press;
KleinG.,
GiovanellaB. C.,
LindahlT.,
FialkowP. J.,
SinghS.,
StehlinJ. S.1974; Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of nasopharynx. Proceedings of the National Academy of Sciences, U.S.A. 71:4737–4741
LauxG.,
PerricaudetM.,
FarrellP. J.1988; A spliced Epstein-Barr virus gene expressed in immortalized lymphocytes is created by circularization of the linear viral genome. EMBO Journal 1:769–774
LenoirG. M.,
VuillaumeM.,
BonnardelC.1985 The use of lymphomatous and lymphoblastoid cell lines in the study of Burkitt’s lymphoma. In Burkitt’s Lymphoma: A Human Cancer Model pp. 309–318 Edited by
LenoirG. M.,
O’ConorG.,
OlwenyC. L.
Lyon: IARC Scientific Publications;
LongneckerR.,
KieffE.1990; A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1. Journal of Virology 64:2319–2326
LongneckerR.,
DrukerB.,
RobertsT. M.,
KieffE.1991; An Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase. Journal of Virology 65:3681–3692
MannK. P.,
StantonD.,
Thorley-LawsonD. A.1985; Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells. Journal of Virology 55:710–720
MillerG.,
LipmanM.1973; Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proceedings of the National Academy of Sciences, U.S.A. 70:190–194
OldL. J.,
CliffordP.,
BoyseE. A.,
De HarvenE.,
GeeringG.,
OettgenH. F.,
WilliamsonB.1966; Precipitating antibody in human serum to an antigen present in cultured Burkitt’s lymphoma cells. Proceedings of the National Academy of Sciences, U.S.A. 56:1699–1704
RoweD. T.,
HallL.,
JoabI.,
LauxG.1990; Identification of the Epstein-Barr virus terminal protein gene products in latently infected lymphocytes. Journal of Virology 64:2866–2875
RoweM.,
FinkeJ.,
SzigetiR.,
KleinG.1988; Characterization of the serological response in man to the latent membrane protein and the six nuclear antigens encoded by Epstein-Barr virus. Journal of General Virology 69:1217–1228
SeigneurinJ. M.,
La voueM. F.,
GenoulazO.,
BornkammG. W.,
LenoirG. M.1987; Antibody response against the Epstein-Barr virus-encoded nuclear antigen 2 (EBNA2) in different groups of individuals. International Journal of Cancer 40:349–353
SmithP. R.,
GriffinB. E.1991; Differential expression of Epstein-Barr viral transcripts for two proteins (TP1 and LMP) in lymphocyte and epithelial cells. Nucleic Acids Research 19:2435–2440
SpindlerK. R.,
RosserD. S. E.,
BerkA. J.1984; Analysis of adenovirus transforming proteins from early regions 1A and IB with antisera to inducible fusion antigens produced in Escherichia coli. Journal of Virology 49:132–141
SummersM. D.,
SmithG. E.1987; A manual of methods for baculovirus vectors and insect culture procedures. Texas Agricultural Experiment Station Bulletin no. 1555
TanR. S.,
ChengY. C.,
NaegeleR. F.,
HenryW.,
GlaserR.,
ChampionJ.1982; Antibody responses to Epstein-Barr virus specific DNAase in relation to the prognosis of juvenile patients with nasopharyngeal carcinoma. International Journal of Cancer 30:561–565
TowbinH.,
StaehelinT.,
GordonJ.1979; Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of Sciences, U.S.A. 76:4350–4354